We are live on
!
Find out more
GC
Globeflex Capital Portfolio holdings
AUM
$661M
1-Year Est. Return
50.59%
This Fund
S&P 500
This Quarter
Est. Return
+9.03%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$351M
AUM Growth
-$54.2M
(-13%)
Cap. Flow
-$77M
Cap. Flow
% of AUM
-21.93%
Top 10 Holdings %
Top 10 Hldgs %
19.59%
Holding
444
New
34
Increased
45
Reduced
121
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TECD
Tech Data Corp
TECD
|
+$2.4M |
| 2 |
AdvanSix
ASIX
|
+$1.99M |
| 3 |
Houlihan Lokey
HLI
|
+$1.84M |
| 4 |
ANI Pharmaceuticals
ANIP
|
+$1.28M |
| 5 |
WisdomTree India Earnings Fund ETF
EPI
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemours
CC
|
+$5.63M |
| 2 |
Extreme Networks
EXTR
|
+$2.95M |
| 3 |
United Rentals
URI
|
+$2.42M |
| 4 |
Labcorp
LH
|
+$2.35M |
| 5 |
NEFF
Neff Corporation
NEFF
|
+$2.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.08% |
| 2 | Consumer Discretionary | 15.51% |
| 3 | Industrials | 14.44% |
| 4 | Technology | 12.75% |
| 5 | Financials | 12.42% |
Similar funds
HIG
RCG
FM
ACM
UCMOK
DC
FAM
CAM
Globeflex Capital's Q3 2017 Portfolio in Review
As of Q3 2017, Globeflex Capital held 444 positions worth $351M, down 13% from $405M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Globeflex Capital withdrew a net $77M in Q3 2017, closing 62 positions and reducing 121 holdings. Its most notable exit was Labcorp, an estimated $2.35M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Globeflex Capital opened a new position in Tech Data Corp worth $2.16M.
- Globeflex Capital's largest Q3 2017 buy was Tech Data Corp: 24,340 shares worth $2.16M.
- Globeflex Capital added most to WisdomTree India Earnings Fund ETF in Q3 2017, an estimated $1.27M increase.
- Globeflex Capital's biggest Q3 2017 reduction was Chemours, cutting an estimated $5.63M.
- Globeflex Capital fully exited Labcorp in Q3 2017, selling an estimated $2.35M.
- Globeflex Capital's ten largest holdings make up 20% of its $351M portfolio in Q3 2017.
- Globeflex Capital opened 34 new positions and closed 62 in Q3 2017.
- Globeflex Capital's portfolio value fell 13% quarter-over-quarter to $351M.
Based on Globeflex Capital's 13F filing for Q3 2017, filed 13 Nov 2017.